Form 4: Anebulo Pharmaceuticals Director Nathaniel Calloway Granted Stock Options and Appoints Attorneys-in-Fact for SEC Filings

Nathaniel Calloway, a director at Anebulo Pharmaceuticals, received stock options and granted power of attorney to Richard Cunningham and Daniel George for SEC reporting obligations.

Summary

• Nathaniel Calloway, a director of Anebulo Pharmaceuticals, Inc., filed a Form 4 indicating changes in beneficial ownership.
• Calloway was granted stock options to purchase 41,667 shares of common stock at an exercise price of $2.10 on June 13, 2024, vesting in two tranches.
• 50% of the options vest on the date of the 2024 annual meeting of shareholders, and the remaining 50% vest one year later.
• Calloway also received stock options to purchase 1,655 shares of common stock at an exercise price of $2.10 on June 13, 2024, vesting on the earlier of November 30, 2024, or the date of the 2024 annual meeting of shareholders.
• Calloway also executed a Limited Power of Attorney, appointing Richard Cunningham and Daniel George as attorneys-in-fact to handle SEC filings related to Section 16 reporting obligations.

Sentiment

Score: 6

Explanation: The document reflects standard corporate governance procedures and executive compensation practices, indicating a neutral sentiment.

Positives

• The granting of stock options to a director aligns their interests with those of the shareholders.
• The Power of Attorney ensures timely and accurate SEC filings.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Stock option grants are a common practice in the pharmaceutical industry to incentivize and retain key personnel. SEC filings related to changes in beneficial ownership are standard regulatory requirements.

Comparison to Industry Standards

• Stock option grants are a typical component of executive compensation packages in the pharmaceutical industry, similar to companies like Pfizer, Merck, and Johnson & Johnson.
• The vesting schedules described are also common, often tied to performance metrics or continued employment, aligning with industry norms.

Stakeholder Impact

• Shareholders may view the stock option grants as a way to align management's interests with the company's performance.
• The Power of Attorney ensures compliance with SEC regulations, protecting shareholder interests.

Next Steps

• The attorneys-in-fact will handle future SEC filings on behalf of Nathaniel Calloway.
• The stock options will vest according to the specified schedule.

Key Dates